The U.S. Food and Drug Administration’s heavily criticized tobacco program promised changes on Friday, including a five-year strategic plan to better outline priorities.
After criticism, FDA pledges to revamp its tobacco division
The U.S. Food and Drug Administration's heavily criticized tobacco program promised changes on Friday, including a five-year strategic plan to better outline priorities.